Zobrazeno 1 - 10
of 22
pro vyhledávání: '"D. L. HERALD"'
Autor:
Jean M. Schmidt, George R. Pettit, Ernest Hamel, D. L. Herald, Monte R. Rhodes, Robin K. Pettit
Publikováno v:
Journal of Medicinal Chemistry. 48:4087-4099
A series of cis- and trans-stilbenes related to combretastatin A-4 (1a), with a variety of substituents at the 3‘-position of the aryl B-ring, were synthesized and evaluated for inhibitory activity employing six human cancer cell lines (NCI-H460 lu
Autor:
Larry V. Pearce, Peter M. Blumberg, George R. Pettit, Robin K. Pettit, Holger Hoffmann, John C. Knight, Kerianne C. Higgs, Alison A. Murphy, Nancy E. Lewin, D. L. Herald, James McNulty, Ernest Hamel
Publikováno v:
The Journal of Organic Chemistry. 69:2251-2256
Aaptamine (1) was used as starting material for synthetic transformation to isoaaptamine (2), 9-demethylaaptamine (5), and 4-methylaaptamine (6). A general method for the selective O-demethylation of such 1H-benzo[de][1,6]-naphthyridine (1) marine sp
Publikováno v:
ChemInform. 22
Publikováno v:
ChemInform. 25
Autor:
Jayaram K. Srirangam, Sheo B. Singh, Thomas L. Groy, D. L. Herald, M. D. Williams, G. R. Pettit, Jozsef Barkoczy, Darko Kantoci, Fiona Hogan
Publikováno v:
ChemInform. 25
Autor:
Michael R. Boyd, E. J. Flahive, J. T. Mullaney, T. J. Thornton, G. R. Pettit, Sheo B. Singh, D. L. Herald
Publikováno v:
ChemInform. 26
Autor:
M. Penny, M. D. Williams, John N. A. Hooper, T. J. Bond, Robin K. Pettit, G. R. Pettit, Dennis L. Doubek, D. L. Herald
Publikováno v:
ChemInform. 28
Autor:
Robin K. Pettit, Jean-Charles Chapuis, Rui Tan, D. L. Herald, Zbigniew A. Cichacz, Noeleen Melody, M. S. Hoard, G. R. Pettit
Publikováno v:
ChemInform. 29
Autor:
G R, Pettit, R, Tan, N, Melody, J M, Kielty, R K, Pettit, D L, Herald, B E, Tucker, L P, Mallavia, D L, Doubek, J M, Schmidt
Publikováno v:
Bioorganicmedicinal chemistry. 7(5)
A Montana soil actinomycete, Streptomyces anulatus, produced (1 x 10(-2)% yield) a new cancer cell growth inhibitory cyclooctadepsipeptide named montanastatin (1) accompanied by the potent anticancer antibiotic valinomycin (2) in very high (5.1%) yie
Autor:
G R, Pettit, M R, Rhodes, D L, Herald, D J, Chaplin, M R, Stratford, E, Hamel, R K, Pettit, J C, Chapuis, D, Oliva
Publikováno v:
Anti-cancer drug design. 13(8)
The (E)-stilbene isomer (2a) of the (Z)-combretastatin A-4 prodrug (1b) was efficiently prepared from (E)-combretastatin A-4 by a reaction sequence employing phosphorylation (dibenzyl chlorophosphite), cleavage (trimethyliodosilane) of the benzyl est